scispace - formally typeset
T

Tiffany G. Sheu

Researcher at National Center for Immunization and Respiratory Diseases

Publications -  20
Citations -  1575

Tiffany G. Sheu is an academic researcher from National Center for Immunization and Respiratory Diseases. The author has contributed to research in topics: Neuraminidase & Oseltamivir. The author has an hindex of 16, co-authored 19 publications receiving 1529 citations. Previous affiliations of Tiffany G. Sheu include Battelle Memorial Institute.

Papers
More filters
Journal ArticleDOI

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

TL;DR: The recent increase in oseltamivir resistance among A(H1N1) viruses isolated from untreated patients raises public health concerns and necessitates close monitoring of resistance to NA inhibitors.
Journal Article

Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

TL;DR: Detailed information is provided on the drug susceptibility of the newly detected S-OIVs, which will aid in making recommendations for treatment and prophylaxis for swine influenza A (H1N1) infection and contribute to antiviral-resistance monitoring and diagnostic test development.
Journal ArticleDOI

Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing

TL;DR: The detection of the first cases of the oseltamivir resistance-conferring mutation H275Y and the I223V change in viruses from the United States using the approach described in this study.
Journal ArticleDOI

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro

TL;DR: The majority of 2009 pandemic influenza A (H1N1) surveillance viruses collected globally were resistant to adamantanes and sensitive to NAIs, except for H275Y variants, which exhibited approximately 100-fold reduction in peramivir susceptibility.
Journal ArticleDOI

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

TL;DR: A pyrosequencing assay for detection of the most commonly reported mutations associated with resistance to NAIs, a newer class of anti-influenza drugs, and designed primers to detect substitutions at D151 in NAs of N1 and N2 subtypes.